Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P4502B6 gene in HepG2 cells

被引:51
作者
Swales, K [1 ]
Kakizaki, S [1 ]
Yamamoto, Y [1 ]
Inoue, K [1 ]
Kobayashi, K [1 ]
Negishi, M [1 ]
机构
[1] NIEHS, NIH, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1074/jbc.M411318200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The constitutive active receptor (CAR) regulates the induction of the cytochrome P450 2B6 (CYP2B6) gene by phenobarbital-type inducers, such as 1,4 bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) via the distal phenobarbital-responsive enhancer module (PBREM, at -1732/-1685 bp). Activation of the PBREM by TCPOBOP generated a 10-fold induction of CYP2B6 mRNA in HepG2 cells stably expressing mouse CAR (Ym17). Co-treatment with the protein phosphatase inhibitor okadaic acid (OA) synergistically increased this induction over 100-fold without directly activating CAR or the PBREM. Although OA synergy required the presence of PBREM, deletion assays delineated the OA-responsive activity to a proximal 24-bp (-256/-233) sequence (OARE) in the CYP2B6 promoter. CAR did not directly bind to the OARE in electrophoretic mobility shift assays. However, both DNA affinity and chromatin immunoprecipitation assays showed a significant increase in CAR association with the OARE after co-treatment with TCPOBOP and OA, indicating the indirect binding of CAR to the OARE. The two cis-acting elements, the distal PBREM and the proximal OARE, within the chromatin structure are both regulated by CAR in response to TCPOBOP and OA, respectively, to maximally induce the CYP2B6 promoter. This functional interaction between the two sites expands the current understanding of the mechanism of CAR-mediated inducible transcription.
引用
收藏
页码:3458 / 3466
页数:9
相关论文
共 48 条
[1]   Context-dependent transcription: all politics is local [J].
Alvarez, M ;
Rhodes, SJ ;
Bidwell, JP .
GENE, 2003, 313 :43-57
[2]   THE ORNITHINE DECARBOXYLASE GENE IS A TRANSCRIPTIONAL TARGET OF C-MYC [J].
BELLOFERNANDEZ, C ;
PACKHAM, G ;
CLEVELAND, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7804-7808
[3]   The crystal structure of an intact human Max-DNA complex: New insights into mechanisms of transcriptional control [J].
Brownlie, P ;
Ceska, TA ;
Lamers, M ;
Romier, C ;
Stier, G ;
Teo, H ;
Suck, D .
STRUCTURE, 1997, 5 (04) :509-520
[4]   DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation [J].
Cheung, E ;
Mayr, P ;
Coda-Zabetta, F ;
Woodman, PG ;
Boam, DSW .
BIOCHEMICAL JOURNAL, 1999, 344 :145-152
[5]   Gene induction by phenobarbital: An update on an old question that receives key novel answers [J].
Corcos, L ;
Lagadic-Gossmann, D .
PHARMACOLOGY & TOXICOLOGY, 2001, 89 (03) :113-122
[6]   Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation [J].
Eckner, R ;
Yao, TP ;
Oldread, E ;
Livingston, DM .
GENES & DEVELOPMENT, 1996, 10 (19) :2478-2490
[7]   PKA, PKC, and the protein phosphatase 2A influence HAND factor function: A mechanism for tissue-specific transcriptional regulation [J].
Firulli, BA ;
Howard, MJ ;
McDaid, JR ;
McIlreavey, L ;
Dionne, KM ;
Centonze, VE ;
Cserjesi, P ;
Virshup, DM ;
Firulli, AB .
MOLECULAR CELL, 2003, 12 (05) :1225-1237
[8]   Retinoic acid receptors and muscle b-HLH proteins:: partners in retinoid-induced myogenesis [J].
Froeschlé, A ;
Alric, S ;
Kitzmann, M ;
Carnac, G ;
Auradé, F ;
Rochette-Egly, C ;
Bonnieu, A .
ONCOGENE, 1998, 16 (26) :3369-3378
[9]   CYCLIC AMPLIFICATION AND SELECTION OF TARGETS FOR MULTICOMPONENT COMPLEXES - MYOGENIN INTERACTS WITH FACTORS RECOGNIZING BINDING-SITES FOR BASIC HELIX LOOP HELIX, NUCLEAR FACTOR-I, MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR-II, AND COMP1 FACTOR [J].
FUNK, WD ;
WRIGHT, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) :9484-9488
[10]  
Galibert MD, 1997, J IMMUNOL, V159, P6176